Celestica's $3 Billion Dilution Blow Caps a Real AI Story

Celestica Raised $3 Billion, and the Market Repriced the Shares

Celestica has added a large pool of fresh equity to a business with real AI demand behind it, and investors responded to the dilution first.

The market focused on dilution before fundamentals

The headline number matters: $3 billion of gross proceeds from an offering priced at $310 per share for 9,677,419 common shares. That is a major capital event, and it means future earnings have to support a bigger share base. The business story still works, but the rerating now has to be earned.

The market's first read was blunt. Shares fell more than 11% in extended trading after the announcement, even though the stock had already gained nearly 20% year to date. This is, at least initially, a supply-and-demand reaction: more shares hitting the market can pressure a stock even when the underlying business is still intact.

Operating Results Still Support the Core AI Narrative

The dilution headline changed the setup, but it did not erase the operating story. The key question now is whether Celestica can generate enough per-share growth to offset the larger equity base.

Q2 results still show strong execution

Celestica just posted Q2 2026 revenue of $4.70 billion, up from $2.89 billion a year earlier, and raised its 2026 revenue outlook to $20.5 billion. It also reported adjusted EPS of $2.54 and an adjusted operating margin of 8.2%, both above the high end of guidance, along with 2026 adjusted EPS guidance of $11.30. Those figures still support the case that this is a real AI-infrastructure business, not just a narrative.

Management also said the capital will support multi-year demand from its customer base. If execution holds, dilution should matter less over time. If growth or margins slip, the larger share count will be easier for the market to punish.

What Investors Need to Watch After the Offering

After the financing, the story is less about whether Celestica has demand and more about whether it can turn that demand into per-share value at the same pace.

The basic bull case still depends on margin and EPS leverage

Management said 2026 revenue growth is expected to be 65% and that revenue growth in 2027 to accelerate beyond the 65% growth rate it expects in 2026. It also said adjusted EPS is expected to grow at a faster rate than revenue in 2027. If that happens, the equity issue starts to look more like a temporary step than a lasting problem.

The dilution overhang is not fully settled

The company has already priced 9,677,419 common shares, but the underwriters also have an option to buy up to an additional 1,451,612 common shares within 30 days of the final prospectus supplement. If that option is exercised after a weak reading of the deal, additional supply could keep weighing on the stock.

Proceeds are broad-based, not project-specific

Management said net proceeds will be used for working capital and to support investments in capital expenditures, in addition to other general corporate purposes. That gives management flexibility, but it also means there is no named project or explicit payback schedule to track. Investors will need proof that the extra capital is improving future per-share outcomes, not just funding growth in the aggregate.

What changes the verdict from here?

The stock looks more attractive if it stabilizes after the offering and management continues to expand margins and EPS faster than the share count increases. If that does not happen, the larger equity base is likely to keep capping upside, even if the underlying AI demand story remains valid.